Luneau Technology Announces Capital Investment in Latham & Phillips Ophthalmic

By

CUMMING, Ga.—The Luneau Technology group, based in France, which develops, manufactures and markets Briot and Weco edgers and Visionix refraction and diagnostic instruments, has announced a capital investment in Latham & Phillips Ophthalmic (L.P.O.), an ophthalmic equipment distributor based in Columbus, Ohio. Luneau declined to disclose the value of the investment or its stake in L.P.O.

“It’s a great opportunity for Luneau Technology to expand visibility of the Visionix brand with this partnership,” said Dr. Marc Abitbol CEO and president of Luneau. “We are also very happy that the present management under the leadership of Mr. Phill Phillips will continue to grow the company. Luneau Technology’s dynamic products combined with L.P.O’s market access and experience will provide the basis for our development in the U.S. The Visionix brand completes the range of L.P.O offerings with high-tech diagnostic equipment based on wavefront technology, and a range of patents in the ophthalmic optical sector.”

Phillips, who is president of L.P.O. and a founder of the 30-year-old company, said, “We have only one durable objective: customer satisfaction. I believe this partnership, which combines the L.P.O strength in the marketplace with the Visionix technology, will provide a unique offering to the U.S. ophthalmic market.”

Luneau Technology, with U.S. headquarters here, specializes in ophthalmic diagnostic products through the Visionix brand. L.P.O distributes and services a wide range of ophthalmic products.